Patent Grant
11672636
The present invention relates to a preformed three-dimensional prosthesis to be used for repair of inguinal hernias.
In this application, the “medial” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the median plane of the body when the prosthesis is implanted in the body. The “lateral” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the outwards lateral plane of the body when the prosthesis is implanted in the body. Likewise, in this application, the “medial direction” is to be understood as meaning the direction towards said median plane and the “lateral direction” is opposite the “medial direction”, the medial and lateral directions being aligned on the same axis, the medial-lateral axis. In this application, the “superior” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located substantially in the direction of the head of the body when the prosthesis is implanted in the body. The “inferior” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the feet of the body when the prosthesis is implanted in the body. Likewise, in this application, the “superior direction” is to be understood as meaning the direction towards said head and the “inferior direction” is opposite the “superior direction”, the superior and inferior directions being aligned on the same axis, the superior-inferior axis. In this application, the “front” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located substantially in the direction of the front of the body when the prosthesis is implanted in the body. The “rear” end or part of an element of a prosthesis is to be understood as meaning the end or part of the element located in the direction of the back of the body when the prosthesis is implanted in the body. Likewise, in this application, the “front direction” is to be understood as meaning the direction towards said front and the “rear direction” is opposite the “front direction”, the front and rear directions being aligned on the same axis, the front-rear axis.
The abdominal wall in humans is composed of fat and muscles interconnected by fascias. It sometimes happens that a break in continuity occurs in the fascias, allowing part of the peritoneum to slip through and form a sac, or a hernia, containing either fat or part of the intestines. Hernias or incisional hernias (a hernia occurring through a parietal surgical scar) show themselves in the form of a bulge at the surface of the skin and are classed, for example, as umbilical or inguinal hernias, depending on where they are located.
Wall reinforcement prostheses, for example for the abdominal wall, are widely used in surgery. These prostheses are intended to treat hernias by temporarily or permanently filling a tissue defect. These prostheses are generally made from a biocompatible prosthetic textile and can have a number of shapes, for example rectangular, circular or oval, depending on the anatomical structure to which they are to adapt. Some of these prostheses may show three-dimensional shapes.
Indeed, when an inguinal hernia is to be treated, it is of particular importance to take into account the anatomy of the inguinal region, in particular the presence of the iliac vessels. In addition, when the patient is a man, the spermatic cord needs to be taken into account while positioning the prosthesis. The various anatomical organs to be taken into account confer to the inguinal region to be treated a three-dimensional shape. In addition, the shape of the inguinal region being asymetric, the shape of a prosthesis intended to be used for treating an inguinal hernia will be dependent on the side (right or left) of the body that is to be treated. In this view, the shape of a prosthesis for treating an inguinal hernia may be defined in relation with the position of the prosthesis once implanted in the body of a patient. For example, in an implanted configuration, a three-dimensional prosthesis for treating an inguinal hernia may comprise a medial part, a lateral part, a superior part, an inferior part, a front part and a rear part as defined above.
With reference to
On
It will be noted in
When operating by laparoscopy for repairing an inguinal hernia, two routes may be used for bringing the prosthesis to the implantation site, namely the inguinal region. For example, according to a first surgical method, namely the transabdominal preperitoneal route (TAPP), the prosthesis is first conveyed to the abdominal cavity via a trocar; the peritoneum is then open and the prosthesis is brought to the inguinal region through the incision performed through the peritoneum. The peritoneum is closed once the implantation is completed. According to a second surgical method, namely the totally extra-peritoneal route (TEP), the prosthesis is brought to the inguinal region through a trocar directly through the muscles of the abdominal wall, and the peritoneum is not open.
Because of the obliqueness of the inguinal region and the restricted deployment space, it can prove complicated to deploy the prosthesis and then orient it suitably with respect to the orifice of the inguinal canal or to the other organs to be protected, such as the illiac vessels or the spermatic cord.
The effectiveness of the prosthesis, hence the ability to minimize the risks of recurrence, depends to a large extent on how well the prosthesis is correctly spread out against the biological tissues of the inguinal region. In the present application, “biological tissues of the inguinal region” are understood as the biological tissues of the organs or elements of the inguinal region that are shown in
Indeed, prostheses based on a textile are generally flexible. In order to introduce them into a trocar, they are often folded up or rolled to reduce their volume. They therefore tend to form creases when introduced at the implantation site. The spreading out of textile based prosthesis from the trocar is of key importance but can prove difficult.
Document U.S. Pat. No. 6,723,133 describes a preformed three-dimensional prosthesis for the repair of inguinal hernia intended to conform to the anatomical shape of the defective wall. The prosthesis described in this patent comprises a plurality of distinctly shaped portions joined to each other, all said shaped portions being configured with a substantially spherical shape.
As seen above, the anatomy of the inguinal region implies various organs such as muscles having various shapes, vessels, such as the illiac vessels, having various paths, and the pubic bone. In addition, the anatomy of the inguinal region may vary significantly from one human being to the other, in particular in its medial inferior area, in the surroundings of the upper part of the pubic bone. It has been observed that, with some preformed three-dimensional protheses of the prior art, this medial inferior area of the inguinal region is not covered efficiently. In particular, depending on the true anatomy of the patient being treated, the surgeon may need to apply a certain tension on the prosthesis or shift the prosthesis at the moment of positioning the prosthesis, so that a part of the prosthesis be present in the medial inferior area of the inguinal region, namely in the surroundings of the pubic bone. Alternatively the surgeon may need to create folds in the prosthesis so as to conform it to the specific shape of the medial inferior area of the inguinal region he is confronted to in relation with the patient he is treating.
There is therefore still the need for a prosthesis for repair of inguinal hernias that is based on a preformed three-dimensional piece of biocompatible material intended to globally conform to the anatomical shape of the defective wall in the inguinal region, that is able to be spread out from the trocar and cover efficiently not only said defective wall but also the medial inferior area of the inguinal region, whatever the true anatomical shape of said medial inferior area in the patient to be treated, such that the surgeon does not have to apply specific tensions on the prosthesis or create folds when positioning the prosthesis with respect to the biological tissues.
The present invention aims to meet such a need.
A first aspect of the invention is an implantable prosthesis for repairing a hernia defect in an inguinal region of a human body delimited by the anterior abdominal wall, the psoas muscle and a medial inferior area of the inguinal anatomy, the prosthesis comprising:
The prosthesis of the invention has a shape allowing it to conform ideally to the anatomy of the inguinal region to be reinforced. In particular, the shape and dimension of the first, second and third portions allow adapting the prostheses to different types of inguinal hernia, such as the direct inguinal hernia, the indirect inguinal hernia and the femoral inguinal hernia.
Moreover, the presence of the third portion of the prosthesis of the invention and the specific shape of this third portion allow covering the medial inferior area of the inguinal anatomy, in particular the region around the upper part of the pubic bone, without having to tear or stretch the other parts of the prosthesis or to create additional folds likely to undesirably interfere with the surrounding organs. Indeed, the presence of this third portion and its shape allow the surgeon to easily lay the entire prosthesis on each anatomical element to be protected without having to apply a particular compensating force on another part of the prosthesis or to shift the prosthesis. The prosthesis is perfectly spread out in the three dimensions of the inguinal region to be repaired, with no need to create folds in the prosthesis in order to conform it to the shape of the anatomy to be protected. There is no tension created in the prosthesis when it is positioned.
The prosthesis of the invention is intended to be used for repairing a hernia defect in the inguinal region of a human body. The prosthesis of the invention is particularly adapted for use in laparoscopic surgery, either via the transabdominal preperitoneal route (TAPP) or the totally extra-peritoneal route (TEP).
The inguinal region may be delimited by the anterior abdominal wall, the psoas muscle and a medial inferior area of the inguinal anatomy, in the surroundings of the pubic bone.
The prosthesis of the invention comprises a piece of biocompatible material having a preformed three-dimensional shape. The piece of biocompatible material comprises several portions, each having a determined shape, the assembly of these determined shapes forming the preformed three-dimensional shape. The piece of biocompatible material is preferably made as a unitary structure.
In the present application, “biocompatible” is understood as meaning that the materials having this property can be implanted in the human or animal body.
Biocompatible materials for forming hernia repair prosthesis are well known in the art. For example, the biocompatible material may comprise a bioresorbable, a non-bioresorbable material and mixtures thereof.
In the present application, “bioresorbable” or “biodegradable” is understood to mean that the materials having this property are absorbed and/or degraded by the tissues or washed from the implantation site and disappear in vivo after a certain time, which may vary, for example, from a few hours to a few years, depending on the chemical nature of the materials.
Examples of bioresorbable material suitable for the piece of the prosthesis of the invention can be chosen from among the following bioresorbable materials: polylactic acid (PLA), polycaprolactones (PCL), polydioxanones (PDO), trimethylene carbonates (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHA), oxidized cellulose, polyglycolic acid (PGA), polyethylene glycol (PE), copolymers of these materials, and mixtures thereof.
Examples of non-bioresorbable material suitable for the piece of the prosthesis of the invention can be chosen from among the following non-bioresorbable materials: polypropylenes, polyesters such as polyethylene terephthalates, polyamides, silicones, polyether ether ketone (PEEK), polyarylether ether ketone (PAEK) and mixtures thereof.
The piece may be made from a preformed sheet of foam, preferably a porous material. Within the meaning of the present application, “porous material” is understood as a material having pores, voids or holes, that are open and are distributed uniformly or irregularly and promote cell colonization and tissue ingrowth. The pores can be present in all types of configurations, for example as spheres, channels, hexagonal forms.
In embodiments, the piece of biocompatible material comprises a textile, in particular a porous textile. In embodiments, the piece of biocompatible material consists in a textile, for example a porous textile.
According to the present invention, “textile” is understood as any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or non-woven. Biocompatible textiles, in particular porous textiles, suitable for the repair of a hernia defect are well known in the art.
The piece of biocompatible material of the prosthesis of the invention comprises a first portion forming a partial spherical cap surface. The partial spherical cap surface is intended to face the anterior abdominal wall. The partial spherical cap surface may extend in the front direction, namely towards the abdominal wall. The partial spherical cap surface is shaped and dimensioned so as to conform to the shape of the anterior abdominal wall. A spherical cap suitable for forming said first portion may derive from a sphere having a diameter ranging from about 200 mm to about 220 mm, preferably ranging from about 206 mm to about 215 mm, said spherical cap having a height ranging from about 15 mm to about 35 mm, preferably from about 20 mm to about 28 mm. The partial spherical cap suitable for obtaining the surface forming the first portion may result from the removal of an inferior part of the spherical cap along a wavy line forming an inferior edge of the first portion.
The piece of biocompatible material of the prosthesis of the invention comprises a second portion forming a wavy-shaped wall intended to face the psoas muscle. The wavy-shaped wall extends from the inferior edge of the first portion and is shaped and dimensioned so as to conform to the shape of the psoas muscle. In embodiments, the wavy-shaped wall extends substantially from a lateral side to a medial side of the piece of biocompatible material and it includes a surface generated by a generatrix, under the form of a straight line D, following a directrix, under the form of a directing curved line C. In embodiments, the directing curved line C includes at least a lateral curve extending substantially in the inferior direction and at least a central curve, offset in the medial direction with respect to said lateral curve, said central curve extending substantially in the superior direction. In embodiments, the directing curved line C further includes a medial curve extending substantially in the inferior direction. The presence or not of the medial curve may depend on the anatomy of the patient to be treated, in particular on the size of the hernia defect to be repaired.
For example, the radius of curvature of the lateral curve may range from about 50 mm to about 55 mm, and may preferably be about 53 mm, the radius of curvature of the central curve may range from about 20 mm to about 35 mm, and may preferably be from about 24 mm to about 31 mm, and the radius of curvature of the medial curve, when present, may range from about 70 mm to about 90 mm, and may preferably be about 80 mm.
The wavy-shaped wall is preferably inclined with respect to the direction of the height of the spherical cap of the first portion. In embodiments, the angle formed between the generatrix of the wavy-shaped wall and the direction of the height of the spherical cap of the first portion may range from about 35° to about 50°, preferably from about 40° to about 45°.
The piece of biocompatible material further comprises a third portion forming an arched part. The arched part extends longitudinally substantially in the inferior direction from a medial inferior corner of said first portion, said arched part extending radially substantially in the front direction, said third portion being intended to face the medial inferior area of the inguinal anatomy. By “arched part” is meant in the present application an angular section of a tube. The radius of the arched part according to the present application is the radius of the tube from which the arched part derives.
In embodiments, the arched part has a radius ranging from about 70 mm to about 110 mm, preferably from about 80 mm to about 100 mm. In embodiments, the arched part extends circumferentially along a portion of a circle forming an angle ranging from about 30° to about 45°, preferably ranging from 33° to 40°. The arched part may have a height ranging from about 20 mm to about 40 mm, preferably from about 21 mm to about 35 mm. The arched part may have a length ranging from about 40 mm to about 60 mm, preferably from about 45 mm to about 53 mm.
The arched part allows covering the various organs present in the medial inferior area of the inguinal region. In particular, the shape and dimension of the arched part allow spreading easily the prosthesis without having to tear it or to create specific folds in order to adapt to the unique anatomy of the patient to be treated.
In embodiments, the height of the arched part is greater or equal, preferably greater, than the height of the spherical cap of the first portion. The arched part is therefore allowed to cover the medial inferior area of the inguinal region while the spherical cap conforms to the shape of the anterior abdominal wall, without having to apply any specific tension on the prosthesis in the front or rear directions.
In embodiments, said preformed three-dimensional shape defining an edge of said piece, said edge extends in the three dimensions of the space. The edge of the piece of biocompatible material follows the anatomy of the region to be protected in an optimum way. In particular, thanks to the fact that the edge of the piece extends in the three dimensions of the space, there is no need for the surgeon to create additional folds of the prosthesis in order to conform it to the anatomic shape to be protected.
In embodiments, said preformed three-dimensional shape defining an edge of said piece, said edge is provided with a reinforcement member at least on a part of its perimeter. The reinforcement member may be made from any biocompatible material and may run continuously or discontinuously along the edge. The reinforcement member may be selected from a moulded material, a wire, a fused textile part and combinations thereof. The reinforcement member is usually provided with a rigidity superior to that of the piece of biocompatible material and may help the handling of the prosthesis during the surgical operation.
In embodiments, the reinforcement member shows no elasticity along the perimeter of the edge. In other words, if one holds the piece at two points of its edge located substantially on a linear section of said edge, and tries to draw away one point from the other, the reinforcement member will show no elongation between the two points. The reinforcement member may therefore constitute a sort of three-dimensional non-elastic belt maintaining the edge of the piece of biocompatible material, where such belt provides a pop-up effect at the time the prosthesis comes out of a trocar for example. The reinforcement member therefore contributes to a more efficient deployment of the prosthesis when it comes out of the trocar.
In embodiments, the piece of biocompatible material may show an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released. The surgeon may therefore be able to reduce the global volume of the prosthesis by applying an outer pressure on the prosthesis so as to fold it on itself at the time he introduces the prosthesis in the trocar. When the prosthesis is released from the trocar on the implantation site, namely in the inguinal region, the prosthesis comes naturally to its initial spread out three-dimensional shape.
A piece of biocompatible material showing such an elasticity may be made from a porous foam.
Alternatively, some textiles may form biocompatible material showing such an elasticity. A textile suitable for forming the piece of the prosthesis of the invention and showing an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released is described in U.S. Pat. No. 6,478,727. For example, such a textile may comprise a porous knit made of polypropylene monofilament yarn having a diameter ranging from about 0.12 mm to about 0.25 mm, preferably from about 0.15 mm to about and 0.20 mm, for example of about 0.18 mm, and threaded one full one empty in two guide bars according to the following knitting pattern according to ISO 11676 standard, publication 2014: Bar I: 3-2/2-1/0-1//, Bar II: 0-1/1-2/3-2//. For example, the number of stitches per centimeter for such a porous knit may vary from about 7 to 15, preferably from about 10 to 12.
In embodiments, the reinforcement member comprises a fused part of a contour of the textile forming the piece of biocompatible material. Alternatively, the reinforcement member may consist in a fused part of a contour of said textile. The fused part of the contour of a textile allows forming a reinforcement member having a smooth outer shape and free of any potential traumatic part. The fused part of the contour of a textile further allows forming a reinforcement member showing no elasticity along the perimeter of the edge. The fused part of the contour of the textile also allows avoiding the self-gripping of the textile.
The contour of the textile may be fused via thermal welding, such as thermal impulse sealing, ultrasonic welding, or induction welding. For example, when thermal impulse sealing is used, the contour of the textile is compressed between two jaws and heated to the melting point of the material forming the textile.
In embodiments, a medial inferior part of the edge is free of any reinforcement member. The absence of any reinforcement member at the medial inferior part of the edge of the piece of the prosthesis of the invention allows the surgeon to freely direct and position the medial inferior part of the prosthesis in function of the shape of the anatomical organs located in the area of the medial inferior area of the inguinal region. Indeed, it is known that the anatomy of the medial inferior area of the inguinal region varies significantly from one human being to the other. Leaving the medial inferior part of the prosthesis free of any reinforced edge enables the surgeon to adapt the positioning and to customize the fixation of the prosthesis in this area to the true shape of the anatomy encountered for a specific patient. The medial inferior part of the prosthesis is therefore more conformable to the anatomical relief encountered in the treated patient.
In embodiments, the piece of biocompatible material is a textile showing an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released, having a reinforcement member which is a fused part of said textile, where the medial inferior part of the edge is free of any reinforcement member. Such embodiments allow having a non-elastic belt, formed by the reinforcement member, maintaining the prosthesis on the main part of its edge, while leaving the medial inferior part of the edge preserve its elasticity, coming from the elasticity of the textile it is made of. Such embodiments allow the surgeons to benefit from the elasticity of the medial inferior part of the edge of the textile in order to easily move the prosthesis in the medial inferior area of the inguinal region and to more freely adapt the position of the prosthesis to this specific part of the anatomy, while at the same time having a prosthesis that has enough global rigidity to be manipulated efficiently and to be spread out easily from the trocar.
In embodiments, the piece further includes a fourth portion extending from the superior-medial part of the first portion, said fourth portion forming a triangular part defining a superior-medial corner of the prosthesis, said corner forming an angle ranging from about 100° to about 120°, preferably from about 105° to about 115°, for example of about 110°. Such a fourth portion allows providing an indication to the surgeon for better positioning the prosthesis. In particular, such a fourth portion helps the surgeon to orientate the prosthesis with regards to the Linea Alba. In addition, the presence of the triangular part forming the fourth portion of the prosthesis allows increasing the surface of the prosthesis in the medial superior area of the inguinal region. Such embodiments are particularly preferred for direct inguinal hernia as they consequently provide additional reinforcement in said medial superior area.
The preformed three-dimensional shape of the prosthesis of the invention may be obtained using any preforming process known in the art, such as a compressive thermoforming process using a traditional two-parts mold. For example, a first part of the mold exhibits an outer surface having the desired shape for the piece of the prosthesis to be obtained and a second part of the mold has a shape similar to that of the first part but recessed into its inner surface. The sheet of biocompatible material, for example a textile, is then secured between the first and the second parts of the mold, the whole being heated at a temperature ranging from about 140° C. to about 150° C. and further cooled down. The preformed three-dimensional shaped piece thus obtained is removed from the mold.
The present invention will become clearer from the following description and from the attached drawings, in which:
With reference to
The piece 2 comprises a first portion 3, which is intended to face the anterior abdominal wall, a second portion 4, which is intended to face the psoas muscle and a third portion 5, which is intended to face the medial inferior area of the inguinal region. In the example shown the piece 2 further comprises a fourth portion 6, intended to ease the alignment of the prosthesis 1 on the Linea Alba. In embodiments not shown, the piece 2 does not comprise such fourth portion. The first portion 3, second portion 4, third portion 5 and fourth portion 6 are all united to form the preformed three-dimensional shaped piece 2 as a unitary structure. The piece 2 has an edge 7 defined by the contour of its preformed three-dimensional shape.
Each portion (3, 4, 5, 6) of the piece 2 of biocompatible material will now be described in detail.
The first portion 3 forms a partial spherical cap surface 8. The partial spherical cap surface 8 is intended to face the anterior abdominal wall once the prosthesis 1 is implanted in the body of a patient. The partial spherical cap surface 8 therefore extends in the front direction, namely towards the abdominal wall. The partial spherical cap surface 8 is shaped and dimensioned so as to conform to the curved shape of the anterior abdominal wall. The partial spherical cap surface 8 is further intended to be positioned adjacent the psoas muscle in an implanted configuration. In this view, the partial spherical cap surface 8 is derived from a spherical cap from which an inferior part has been removed, the inferior part removed corresponding to the presence of the psoas muscle. The partial spherical cap surface 8 may therefore be a spherical cap surface that has been cut in its inferior part along a line delimited by the shape of the psoas muscle. Such a line forms an inferior edge 8a of the partial spherical cap surface 8.
The spherical cap from which the first portion 3 is formed may be obtained from the cutting of a cap from a sphere having a diameter ranging from about 200 mm to about 220 mm, preferably ranging from about 206 mm to about 215 mm, where the cut cap has a height H, as shown on
The second portion 4 forms a wavy-shaped wall 9 intended to face the psoas muscle once the prosthesis 1 is implanted in the body of a patient. The wavy-shaped wall 9 extends from the inferior edge 8a of the first portion 3 and is shaped and dimensioned so as to conform to the shape of the psoas muscle.
With reference to
With reference to
For example, the radius of curvature of the lateral curve 9a, shown as R1 on
The wavy-shaped wall 9 is inclined with respect to the direction of the height “h” of the spherical cap 8 of the first portion 3. With reference to
With reference to
With reference to
The arched part 10 forming the third portion 5 is intended to face the medial inferior area of the inguinal anatomy. The radius R4 of the arched part 10 is the radius of the tube from which the arched part derives and is shown in
The arched part 10 may have a radius R4 ranging from about 70 mm to about 110 mm, preferably from about 80 mm to about 100 mm.
With reference to
Still with reference to
The arched part 10 allows covering the various organs present in the medial inferior area of the inguinal region. In particular, the shape and dimension of the arched part 10 allow spreading easily the prosthesis 1 without having to tear it or to create specific folds in order to adapt to the unique anatomy of the patient to be treated.
Still with reference to
With reference to
With reference to
With reference to
The reinforcement member 11 forms a non-elastic belt maintaining the prosthesis 1 and helps the handling of the prosthesis 1 while providing a pop-up effect when the prosthesis 1 has been folded on itself, like in a trocar for example.
On
The four portions (3, 4, 5, 6) of the prosthesis 1 of
The four portions (3, 4, 5, 6) of the prosthesis 1 of
The reinforcement member 11 may be a fused part of the contour of the textile forming the piece 2, for example obtained by thermal welding. Such a fused part shows a smooth outer shape and is free of any traumatic element. Such a fused part also allows avoiding self-gripping of the textile when the prosthesis is folded on itself during its introduction to the implantation site via a trocar.
When the textile is a porous knit obtained from polypropylene monofilament as described above, the reinforcement member may be obtained by fusing the contour of the textile as follows: the contour of the textile is compressed between two jaws and heated to about 240° C. which is the melting point of polypropylene.
The piece 2 of the prosthesis 1 may be obtained using a compressive thermoforming process: for example, a flat textile such as the textile described above is secured between the two parts of a mold having the desired shape for the piece of the prosthesis to be obtained. The whole is heated at temperature of about 140° C. and then cooled down in order to obtain the preformed three-dimensional shaped piece 2. The preformed three-dimensional shaped piece thus obtained from said textile shows an elasticity allowing it to be deformed when submitted to an outer pressure and to come back to its initial predetermined three-dimensional shape when said outer pressure is released. Fusing the edge of the piece except for the medial inferior part of the edge allows forming a prosthesis capable of spreading out automatically from a trocar and having a good handleability, while showing in its medial inferior part an elasticity enabling the surgeon to conform the prosthesis to the medial inferior area of the inguinal region of the patient being treated.
The prosthesis of the invention is adapted to be used in the repair of inguinal hernia, such as the direct inguinal hernia, the indirect inguinal hernia and/or the femoral inguinal hernia. In particular, the prosthesis of the invention allows covering the medial inferior area of the inguinal anatomy, in particular the region around the upper part of the pubic bone, without having to tear or stretch the other parts of the prosthesis or to create additional folds likely to undesirably interfere with the surrounding organs.
| Number | Date | Country | Kind |
|---|---|---|---|
| 17305489 | May 2017 | EP | regional |
This application is a continuation of U.S. patent application Ser. No. 15/965,826 filed Apr. 27, 2018, which claims benefit of and priority to European Patent Application No. 17305489.1 filed May 2, 2017, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 1187158 | Mcginley | Jun 1916 | A |
| 3054406 | Usher | Sep 1962 | A |
| 3118294 | Laethem | Jan 1964 | A |
| 3124136 | Usher | Mar 1964 | A |
| 3272204 | Artandi et al. | Sep 1966 | A |
| 3276448 | Kronenthal | Oct 1966 | A |
| 3320649 | Naimer | May 1967 | A |
| 3364200 | Ashton et al. | Jan 1968 | A |
| 3570482 | Shigeru et al. | Mar 1971 | A |
| 3718725 | Hamano | Feb 1973 | A |
| 4006747 | Kronenthal et al. | Feb 1977 | A |
| 4060081 | Yannas et al. | Nov 1977 | A |
| 4173131 | Melton et al. | Nov 1979 | A |
| 4193137 | Heck | Mar 1980 | A |
| 4248064 | Odham | Feb 1981 | A |
| 4294241 | Miyata | Oct 1981 | A |
| 4307717 | Hymes et al. | Dec 1981 | A |
| 4338800 | Matsuda | Jul 1982 | A |
| 4476697 | Schäfer et al. | Oct 1984 | A |
| 4487865 | Balazs et al. | Dec 1984 | A |
| 4500676 | Balazs et al. | Feb 1985 | A |
| 4511653 | Play et al. | Apr 1985 | A |
| 4527404 | Nakagaki et al. | Jul 1985 | A |
| 4591501 | Cioca | May 1986 | A |
| 4597762 | Walter et al. | Jul 1986 | A |
| 4603695 | Ikada et al. | Aug 1986 | A |
| 4631932 | Sommers | Dec 1986 | A |
| 4670014 | Huc et al. | Jun 1987 | A |
| 4709562 | Matsuda | Dec 1987 | A |
| 4748078 | Doi et al. | May 1988 | A |
| 4759354 | Quarfoot | Jul 1988 | A |
| 4769038 | Bendavid et al. | Sep 1988 | A |
| 4796603 | Dahlke et al. | Jan 1989 | A |
| 4813942 | Alvarez | Mar 1989 | A |
| 4840629 | Bustos | Jun 1989 | A |
| 4841962 | Berg et al. | Jun 1989 | A |
| 4854316 | Davis | Aug 1989 | A |
| 4925294 | Geshwind et al. | May 1990 | A |
| 4931546 | Tardy et al. | Jun 1990 | A |
| 4942875 | Hlavacek et al. | Jul 1990 | A |
| 4948540 | Nigam | Aug 1990 | A |
| 4950483 | Ksander et al. | Aug 1990 | A |
| 4970298 | Silver et al. | Nov 1990 | A |
| 4976737 | Leake | Dec 1990 | A |
| 5002551 | Linsky et al. | Mar 1991 | A |
| 5015584 | Brysk | May 1991 | A |
| 5071433 | Naestoft et al. | Dec 1991 | A |
| 5116357 | Eberbach | May 1992 | A |
| 5147374 | Fernandez | Sep 1992 | A |
| 5162430 | Rhee et al. | Nov 1992 | A |
| 5171273 | Silver et al. | Dec 1992 | A |
| 5176692 | Wilk et al. | Jan 1993 | A |
| 5192301 | Kamiya et al. | Mar 1993 | A |
| 5195542 | Gazielly et al. | Mar 1993 | A |
| 5196185 | Silver et al. | Mar 1993 | A |
| 5201745 | Tayot et al. | Apr 1993 | A |
| 5201764 | Kelman et al. | Apr 1993 | A |
| 5206028 | Li | Apr 1993 | A |
| 5217493 | Raad et al. | Jun 1993 | A |
| 5254133 | Seid | Oct 1993 | A |
| 5256418 | Kemp et al. | Oct 1993 | A |
| 5258000 | Gianturco | Nov 1993 | A |
| 5263983 | Yoshizato et al. | Nov 1993 | A |
| 5304595 | Rhee et al. | Apr 1994 | A |
| 5306500 | Rhee et al. | Apr 1994 | A |
| 5324775 | Rhee et al. | Jun 1994 | A |
| 5328955 | Rhee et al. | Jul 1994 | A |
| 5334527 | Brysk | Aug 1994 | A |
| 5339657 | Mcmurray | Aug 1994 | A |
| 5350583 | Yoshizato et al. | Sep 1994 | A |
| 5356432 | Rutkow et al. | Oct 1994 | A |
| 5368549 | Mcvicker | Nov 1994 | A |
| 5368602 | Torre | Nov 1994 | A |
| 5370650 | Jonathan et al. | Dec 1994 | A |
| 5376375 | Rhee et al. | Dec 1994 | A |
| 5376376 | Li | Dec 1994 | A |
| 5397331 | Himpens et al. | Mar 1995 | A |
| 5399361 | Song et al. | Mar 1995 | A |
| 5413791 | Rhee et al. | May 1995 | A |
| 5425740 | Hutchinson, Jr. | Jun 1995 | A |
| 5428022 | Palefsky et al. | Jun 1995 | A |
| 5433996 | Kranzler et al. | Jul 1995 | A |
| 5441491 | Verschoor et al. | Aug 1995 | A |
| 5441508 | Gazielly et al. | Aug 1995 | A |
| 5456693 | Conston et al. | Oct 1995 | A |
| 5456711 | Hudson | Oct 1995 | A |
| 5466462 | Rosenthal et al. | Nov 1995 | A |
| 5480644 | Freed | Jan 1996 | A |
| 5487895 | Dapper et al. | Jan 1996 | A |
| 5490984 | Freed | Feb 1996 | A |
| 5512291 | Li | Apr 1996 | A |
| 5512301 | Song et al. | Apr 1996 | A |
| 5514181 | Light et al. | May 1996 | A |
| 5522840 | Krajicek | Jun 1996 | A |
| 5523348 | Rhee et al. | Jun 1996 | A |
| 5536656 | Kemp et al. | Jul 1996 | A |
| 5543441 | Rhee et al. | Aug 1996 | A |
| 5565210 | Rosenthal et al. | Oct 1996 | A |
| 5567806 | Abdul-Malak et al. | Oct 1996 | A |
| 5569273 | Titone et al. | Oct 1996 | A |
| RE35399 | Eisenberg | Dec 1996 | E |
| 5584884 | Pignataro | Dec 1996 | A |
| 5593441 | Lichtenstein et al. | Jan 1997 | A |
| 5595621 | Light et al. | Jan 1997 | A |
| 5601571 | Moss | Feb 1997 | A |
| 5607474 | Athanasiou et al. | Mar 1997 | A |
| 5607590 | Shimizu | Mar 1997 | A |
| 5614587 | Rhee et al. | Mar 1997 | A |
| 5618551 | Tardy et al. | Apr 1997 | A |
| 5634931 | Kugel | Jun 1997 | A |
| 5639796 | Lee | Jun 1997 | A |
| 5665391 | Lea | Sep 1997 | A |
| 5667839 | Berg | Sep 1997 | A |
| 5676967 | Williams et al. | Oct 1997 | A |
| 5681568 | Goldin et al. | Oct 1997 | A |
| 5686090 | Schilder et al. | Nov 1997 | A |
| 5686115 | Vournakis et al. | Nov 1997 | A |
| 5690675 | Sawyer et al. | Nov 1997 | A |
| 5695525 | Mulhauser et al. | Dec 1997 | A |
| 5697978 | Sgro | Dec 1997 | A |
| 5700476 | Rosenthal et al. | Dec 1997 | A |
| 5700477 | Rosenthal et al. | Dec 1997 | A |
| 5702416 | Kieturakis et al. | Dec 1997 | A |
| 5709934 | Bell et al. | Jan 1998 | A |
| 5711960 | Shikinami | Jan 1998 | A |
| 5716409 | Debbas | Feb 1998 | A |
| 5720981 | Eisinger | Feb 1998 | A |
| 5732572 | Litton | Mar 1998 | A |
| 5743917 | Saxon | Apr 1998 | A |
| 5749895 | Sawyer et al. | May 1998 | A |
| 5752974 | Rhee et al. | May 1998 | A |
| 5766246 | Mulhauser et al. | Jun 1998 | A |
| 5766631 | Arnold | Jun 1998 | A |
| 5769864 | Kugel | Jun 1998 | A |
| 5771716 | Schlussel | Jun 1998 | A |
| 5785983 | Furlan et al. | Jul 1998 | A |
| 5800541 | Rhee et al. | Sep 1998 | A |
| 5814328 | Gunasekaran | Sep 1998 | A |
| 5833705 | Ken et al. | Nov 1998 | A |
| 5840011 | Landgrebe et al. | Nov 1998 | A |
| 5861034 | Taira et al. | Jan 1999 | A |
| 5863984 | Doillon et al. | Jan 1999 | A |
| 5869080 | Mcgregor et al. | Feb 1999 | A |
| 5871767 | Dionne et al. | Feb 1999 | A |
| 5876444 | Lai | Mar 1999 | A |
| 5891558 | Bell et al. | Apr 1999 | A |
| 5899909 | Claren et al. | May 1999 | A |
| 5906937 | Sugiyama et al. | May 1999 | A |
| 5910149 | Kuzmak | Jun 1999 | A |
| 5911731 | Pham et al. | Jun 1999 | A |
| 5916225 | Kugel | Jun 1999 | A |
| 5919232 | Chaffringeon et al. | Jul 1999 | A |
| 5919233 | Knopf et al. | Jul 1999 | A |
| 5922026 | Chin | Jul 1999 | A |
| 5931165 | Reich et al. | Aug 1999 | A |
| 5942278 | Hagedorn et al. | Aug 1999 | A |
| 5954767 | Pajotin et al. | Sep 1999 | A |
| 5962136 | Dewez et al. | Oct 1999 | A |
| 5972022 | Huxel | Oct 1999 | A |
| RE36370 | Li | Nov 1999 | E |
| 5993844 | Abraham et al. | Nov 1999 | A |
| 5994325 | Roufa et al. | Nov 1999 | A |
| 5997895 | Narotam et al. | Dec 1999 | A |
| 6001895 | Harvey et al. | Dec 1999 | A |
| 6008292 | Lee et al. | Dec 1999 | A |
| 6015844 | Harvey et al. | Jan 2000 | A |
| 6039686 | Robert | Mar 2000 | A |
| 6042534 | Gellman et al. | Mar 2000 | A |
| 6042592 | Schmitt | Mar 2000 | A |
| 6043089 | Sugiyama et al. | Mar 2000 | A |
| 6051425 | Morota et al. | Apr 2000 | A |
| 6056688 | Benderev et al. | May 2000 | A |
| 6056970 | Greenawalt et al. | May 2000 | A |
| 6057148 | Sugiyama et al. | May 2000 | A |
| 6063396 | Kelleher | May 2000 | A |
| 6066776 | Goodwin et al. | May 2000 | A |
| 6066777 | Benchetrit | May 2000 | A |
| 6071292 | Makower et al. | Jun 2000 | A |
| 6077281 | Das | Jun 2000 | A |
| 6080194 | Pachence et al. | Jun 2000 | A |
| 6083522 | Chu et al. | Jul 2000 | A |
| 6090116 | D Aversa et al. | Jul 2000 | A |
| 6113623 | Sgro | Sep 2000 | A |
| 6120539 | Eldridge et al. | Sep 2000 | A |
| 6132765 | Dicosmo et al. | Oct 2000 | A |
| 6143037 | Goldstein et al. | Nov 2000 | A |
| 6153292 | Bell et al. | Nov 2000 | A |
| 6162962 | Hinsch et al. | Dec 2000 | A |
| 6165488 | Tardy et al. | Dec 2000 | A |
| 6171318 | Kugel et al. | Jan 2001 | B1 |
| 6174320 | Kugel et al. | Jan 2001 | B1 |
| 6176863 | Kugel et al. | Jan 2001 | B1 |
| 6179872 | Bell et al. | Jan 2001 | B1 |
| 6180848 | Flament et al. | Jan 2001 | B1 |
| 6197325 | Macphee et al. | Mar 2001 | B1 |
| 6197934 | Devore et al. | Mar 2001 | B1 |
| 6197935 | Doillon et al. | Mar 2001 | B1 |
| 6210439 | Firmin et al. | Apr 2001 | B1 |
| 6214020 | Mulhauser et al. | Apr 2001 | B1 |
| 6221109 | Geistlich et al. | Apr 2001 | B1 |
| 6224616 | Kugel | May 2001 | B1 |
| 6241768 | Agarwal et al. | Jun 2001 | B1 |
| 6258124 | Darois et al. | Jul 2001 | B1 |
| 6262332 | Ketharanathan | Jul 2001 | B1 |
| 6264702 | Ory et al. | Jul 2001 | B1 |
| 6267772 | Mulhauser et al. | Jul 2001 | B1 |
| 6270530 | Eldridge et al. | Aug 2001 | B1 |
| 6277397 | Shimizu | Aug 2001 | B1 |
| 6280453 | Kugel et al. | Aug 2001 | B1 |
| 6287316 | Agarwal et al. | Sep 2001 | B1 |
| 6290708 | Kugel et al. | Sep 2001 | B1 |
| 6306079 | Trabucco | Oct 2001 | B1 |
| 6306424 | Vyakarnam et al. | Oct 2001 | B1 |
| 6312474 | Francis et al. | Nov 2001 | B1 |
| 6319264 | Tormala et al. | Nov 2001 | B1 |
| 6328686 | Robert | Dec 2001 | B1 |
| 6334872 | Termin et al. | Jan 2002 | B1 |
| 6368541 | Pajotin et al. | Apr 2002 | B1 |
| 6383201 | Dong | May 2002 | B1 |
| 6391060 | Ory et al. | May 2002 | B1 |
| 6391333 | Li et al. | May 2002 | B1 |
| 6391939 | Tayot et al. | May 2002 | B2 |
| 6408656 | Ory et al. | Jun 2002 | B1 |
| 6410044 | Chudzik et al. | Jun 2002 | B1 |
| 6413742 | Olsen et al. | Jul 2002 | B1 |
| 6425924 | Rousseau | Jul 2002 | B1 |
| 6428978 | Olsen et al. | Aug 2002 | B1 |
| 6436030 | Rehil | Aug 2002 | B2 |
| 6440167 | Shimizu | Aug 2002 | B2 |
| 6443964 | Ory et al. | Sep 2002 | B1 |
| 6447551 | Goldmann | Sep 2002 | B1 |
| 6447802 | Sessions et al. | Sep 2002 | B2 |
| 6448378 | Devore et al. | Sep 2002 | B2 |
| 6451032 | Ory et al. | Sep 2002 | B1 |
| 6451301 | Sessions et al. | Sep 2002 | B1 |
| 6454787 | Maddalo et al. | Sep 2002 | B1 |
| 6477865 | Matsumoto | Nov 2002 | B1 |
| 6479072 | Morgan et al. | Nov 2002 | B1 |
| 6485503 | Jacobs et al. | Nov 2002 | B2 |
| 6500464 | Ceres et al. | Dec 2002 | B2 |
| 6500777 | Wiseman et al. | Dec 2002 | B1 |
| 6509031 | Miller et al. | Jan 2003 | B1 |
| 6511958 | Atkinson et al. | Jan 2003 | B1 |
| 6514286 | Leatherbury et al. | Feb 2003 | B1 |
| 6514514 | Atkinson et al. | Feb 2003 | B1 |
| 6540773 | Dong | Apr 2003 | B2 |
| 6541023 | Andre et al. | Apr 2003 | B1 |
| 6548077 | Gunasekaran | Apr 2003 | B1 |
| 6554855 | Dong | Apr 2003 | B1 |
| 6559119 | Burgess et al. | May 2003 | B1 |
| 6566345 | Miller et al. | May 2003 | B2 |
| 6575988 | Rousseau | Jun 2003 | B2 |
| 6576019 | Atala | Jun 2003 | B1 |
| 6596002 | Therin et al. | Jul 2003 | B2 |
| 6596304 | Bayon et al. | Jul 2003 | B1 |
| 6599323 | Melican et al. | Jul 2003 | B2 |
| 6599524 | Li et al. | Jul 2003 | B2 |
| 6599690 | Abraham et al. | Jul 2003 | B1 |
| 6610006 | Amid et al. | Aug 2003 | B1 |
| 6613348 | Jain | Sep 2003 | B1 |
| 6616685 | Rousseau | Sep 2003 | B2 |
| 6623963 | Mueller et al. | Sep 2003 | B1 |
| 6630414 | Matsumoto | Oct 2003 | B1 |
| 6637437 | Hungerford et al. | Oct 2003 | B1 |
| 6638284 | Rousseau et al. | Oct 2003 | B1 |
| 6645226 | Jacobs et al. | Nov 2003 | B1 |
| 6652594 | Francis et al. | Nov 2003 | B2 |
| 6652595 | Nicolo | Nov 2003 | B1 |
| 6653450 | Berg et al. | Nov 2003 | B1 |
| 6656206 | Corcoran et al. | Dec 2003 | B2 |
| 6660280 | Allard et al. | Dec 2003 | B1 |
| 6669735 | Pelissier | Dec 2003 | B1 |
| 6670018 | Fujita et al. | Dec 2003 | B2 |
| 6682760 | Noff et al. | Jan 2004 | B2 |
| 6685714 | Rousseau | Feb 2004 | B2 |
| 6706684 | Bayon et al. | Mar 2004 | B1 |
| 6706690 | Reich et al. | Mar 2004 | B2 |
| 6712859 | Rousseau et al. | Mar 2004 | B2 |
| 6719795 | Bryan et al. | Apr 2004 | B1 |
| 6723133 | Pajotin | Apr 2004 | B1 |
| 6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
| 6726660 | Hessel et al. | Apr 2004 | B2 |
| 6730299 | Tayot et al. | May 2004 | B1 |
| 6736823 | Darois et al. | May 2004 | B2 |
| 6736854 | Vadurro et al. | May 2004 | B2 |
| 6737371 | Planck et al. | May 2004 | B1 |
| 6740122 | Pajotin | May 2004 | B1 |
| 6743435 | Devore et al. | Jun 2004 | B2 |
| 6746458 | Cloud | Jun 2004 | B1 |
| 6752834 | Geistlich et al. | Jun 2004 | B2 |
| 6755868 | Rousseau | Jun 2004 | B2 |
| 6773723 | Spiro et al. | Aug 2004 | B1 |
| 6783554 | Amara et al. | Aug 2004 | B2 |
| 6790213 | Cherok et al. | Sep 2004 | B2 |
| 6790454 | Abdul et al. | Sep 2004 | B1 |
| 6800082 | Rousseau | Oct 2004 | B2 |
| 6833408 | Sehl et al. | Dec 2004 | B2 |
| 6835336 | Watt | Dec 2004 | B2 |
| 6852330 | Bowman et al. | Feb 2005 | B2 |
| 6869938 | Schwartz et al. | Mar 2005 | B1 |
| 6872227 | Sump et al. | Mar 2005 | B2 |
| 6893653 | Abraham et al. | May 2005 | B2 |
| 6896904 | Spiro et al. | May 2005 | B2 |
| 6926723 | Mulhauser et al. | Aug 2005 | B1 |
| 6936276 | Spiro et al. | Aug 2005 | B2 |
| 6939562 | Spiro et al. | Sep 2005 | B2 |
| 6949625 | Tayot | Sep 2005 | B2 |
| 6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
| 6971252 | Therin et al. | Dec 2005 | B2 |
| 6974679 | Andre et al. | Dec 2005 | B2 |
| 6974862 | Ringeisen et al. | Dec 2005 | B2 |
| 6977231 | Matsuda | Dec 2005 | B1 |
| 6984392 | Bechert et al. | Jan 2006 | B2 |
| 6988386 | Okawa et al. | Jan 2006 | B1 |
| 7011688 | Gryska et al. | Mar 2006 | B2 |
| 7021086 | Ory et al. | Apr 2006 | B2 |
| 7022358 | Eckmayer et al. | Apr 2006 | B2 |
| 7025063 | Snitkin et al. | Apr 2006 | B2 |
| 7041868 | Greene et al. | May 2006 | B2 |
| 7060103 | Carr et al. | Jun 2006 | B2 |
| RE39172 | Bayon et al. | Jul 2006 | E |
| 7070558 | Gellman et al. | Jul 2006 | B2 |
| 7087065 | Ulmsten et al. | Aug 2006 | B2 |
| 7094261 | Zotti et al. | Aug 2006 | B2 |
| 7098315 | Schaufler | Aug 2006 | B2 |
| 7101381 | Ford et al. | Sep 2006 | B2 |
| 7115220 | Dubson et al. | Oct 2006 | B2 |
| 7156804 | Nicolo | Jan 2007 | B2 |
| 7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
| 7175852 | Simmoteit et al. | Feb 2007 | B2 |
| 7192604 | Brown et al. | Mar 2007 | B2 |
| 7207962 | Anand et al. | Apr 2007 | B2 |
| 7214765 | Ringeisen et al. | May 2007 | B2 |
| 7226611 | Yura et al. | Jun 2007 | B2 |
| 7229453 | Anderson et al. | Jun 2007 | B2 |
| 7252837 | Guo et al. | Aug 2007 | B2 |
| 7279177 | Looney et al. | Oct 2007 | B2 |
| 7331199 | Ory et al. | Feb 2008 | B2 |
| 7393319 | Merade et al. | Jul 2008 | B2 |
| 7476249 | Frank | Jan 2009 | B2 |
| 7556598 | Rao | Jul 2009 | B2 |
| 7594921 | Browning | Sep 2009 | B2 |
| 7614258 | Cherok et al. | Nov 2009 | B2 |
| 7615065 | Priewe et al. | Nov 2009 | B2 |
| 7662169 | Wittmann | Feb 2010 | B2 |
| 7670372 | Shfaram et al. | Mar 2010 | B2 |
| 7670380 | Cauthen, III et al. | Mar 2010 | B2 |
| 7682381 | Rakos et al. | Mar 2010 | B2 |
| 7709017 | Tayot et al. | May 2010 | B2 |
| 7718556 | Matsuda et al. | May 2010 | B2 |
| 7732354 | Fricke et al. | Jun 2010 | B2 |
| 7785334 | Ford et al. | Aug 2010 | B2 |
| 7789888 | Bartee et al. | Sep 2010 | B2 |
| 7799767 | Lamberti et al. | Sep 2010 | B2 |
| 7806905 | Ford et al. | Oct 2010 | B2 |
| 7824420 | Eldridge et al. | Nov 2010 | B2 |
| 7828854 | Rousseau et al. | Nov 2010 | B2 |
| 7900484 | Cherok et al. | Mar 2011 | B2 |
| 7931695 | Ringeisen | Apr 2011 | B2 |
| 3007531 | Frank | Aug 2011 | A1 |
| 7998152 | Frank | Aug 2011 | B2 |
| 8052759 | Dupic et al. | Nov 2011 | B2 |
| 8079023 | Chen | Dec 2011 | B2 |
| 8100924 | Browning | Jan 2012 | B2 |
| 8123817 | Intoccia et al. | Feb 2012 | B2 |
| 8142515 | Therin et al. | Mar 2012 | B2 |
| 8157821 | Browning | Apr 2012 | B2 |
| 8157822 | Browning | Apr 2012 | B2 |
| 8182545 | Cherok et al. | May 2012 | B2 |
| 8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
| 8206632 | Rousseau et al. | Jun 2012 | B2 |
| 8215310 | Browning | Jul 2012 | B2 |
| 8317872 | Adams | Nov 2012 | B2 |
| 8323675 | Greenawalt | Dec 2012 | B2 |
| 8343232 | Adzich et al. | Jan 2013 | B2 |
| 8366787 | Brown et al. | Feb 2013 | B2 |
| 8435307 | Paul | May 2013 | B2 |
| 8470355 | Skalla et al. | Jun 2013 | B2 |
| 8506627 | Van et al. | Aug 2013 | B2 |
| 8562633 | Cully et al. | Oct 2013 | B2 |
| 8574627 | Martakos et al. | Nov 2013 | B2 |
| 8709094 | Stad et al. | Apr 2014 | B2 |
| 8728159 | Kim et al. | May 2014 | B2 |
| 8734471 | Deitch | May 2014 | B2 |
| 8746014 | Mortarino | Jun 2014 | B2 |
| 8753360 | Gleiman et al. | Jun 2014 | B2 |
| 8758800 | Stopek et al. | Jun 2014 | B2 |
| 8784294 | Goddard | Jul 2014 | B2 |
| 8814887 | Walther et al. | Aug 2014 | B2 |
| 8828092 | Toso et al. | Sep 2014 | B2 |
| 8834864 | Odar et al. | Sep 2014 | B2 |
| 8846060 | Archibald et al. | Sep 2014 | B2 |
| 8865215 | Ladet et al. | Oct 2014 | B2 |
| 8877233 | Obermiller et al. | Nov 2014 | B2 |
| 8911504 | Mathisen et al. | Dec 2014 | B2 |
| 8920370 | Sholev et al. | Dec 2014 | B2 |
| 8956373 | Ford et al. | Feb 2015 | B2 |
| 8962006 | Bayon et al. | Feb 2015 | B2 |
| 8968762 | Ladet et al. | Mar 2015 | B2 |
| 8979935 | Lozier et al. | Mar 2015 | B2 |
| 9034357 | Stopek | May 2015 | B2 |
| 9113993 | Lee | Aug 2015 | B2 |
| 9211175 | Stopek et al. | Dec 2015 | B2 |
| 9216075 | Bailly et al. | Dec 2015 | B2 |
| 9346791 | Liu et al. | May 2016 | B2 |
| 9713519 | Horton et al. | Jul 2017 | B2 |
| 9931198 | Doucet et al. | Apr 2018 | B2 |
| 10675137 | Bailly | Jun 2020 | B2 |
| 20020087174 | Capello | Jul 2002 | A1 |
| 20020095218 | Carr et al. | Jul 2002 | A1 |
| 20030086975 | Ringeisen | May 2003 | A1 |
| 20030106346 | Matsumoto | Jun 2003 | A1 |
| 20030114937 | Leatherbury et al. | Jun 2003 | A1 |
| 20030133967 | Ruszczak et al. | Jul 2003 | A1 |
| 20030225355 | Butler | Dec 2003 | A1 |
| 20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
| 20040054376 | Ory et al. | Mar 2004 | A1 |
| 20040059356 | Gingras | Mar 2004 | A1 |
| 20040101546 | Gorman et al. | May 2004 | A1 |
| 20050002893 | Goldmann | Jan 2005 | A1 |
| 20050021058 | Negro | Jan 2005 | A1 |
| 20050085924 | Darois et al. | Apr 2005 | A1 |
| 20050113849 | Popadiuk et al. | May 2005 | A1 |
| 20050137512 | Campbell et al. | Jun 2005 | A1 |
| 20050142161 | Freeman et al. | Jun 2005 | A1 |
| 20050148963 | Brennan | Jul 2005 | A1 |
| 20050175659 | Macomber et al. | Aug 2005 | A1 |
| 20050232979 | Shoshan | Oct 2005 | A1 |
| 20050267521 | Forsberg | Dec 2005 | A1 |
| 20050288691 | Leiboff | Dec 2005 | A1 |
| 20060036266 | Sulamanidze et al. | Feb 2006 | A1 |
| 20060116696 | Odermatt et al. | Jun 2006 | A1 |
| 20060135921 | Wiercinski et al. | Jun 2006 | A1 |
| 20060147501 | Hillas et al. | Jul 2006 | A1 |
| 20060216320 | Kitazono et al. | Sep 2006 | A1 |
| 20060252981 | Matsuda et al. | Nov 2006 | A1 |
| 20060253203 | Alvarado | Nov 2006 | A1 |
| 20060282103 | Fricke et al. | Dec 2006 | A1 |
| 20070088391 | Mcalexander et al. | Apr 2007 | A1 |
| 20070129736 | Solecki | Jun 2007 | A1 |
| 20070198040 | Buevich et al. | Aug 2007 | A1 |
| 20070299538 | Roeber | Dec 2007 | A1 |
| 20080091276 | Deusch et al. | Apr 2008 | A1 |
| 20080109017 | Herweck et al. | May 2008 | A1 |
| 20080113001 | Herweck et al. | May 2008 | A1 |
| 20080172071 | Barker | Jul 2008 | A1 |
| 20080255593 | St-Germain | Oct 2008 | A1 |
| 20090035341 | Wagener et al. | Feb 2009 | A1 |
| 20090036996 | Roeber | Feb 2009 | A1 |
| 20090068250 | Gravagna et al. | Mar 2009 | A1 |
| 20090082864 | Chen et al. | Mar 2009 | A1 |
| 20090105526 | Piroli et al. | Apr 2009 | A1 |
| 20090163936 | Yang et al. | Jun 2009 | A1 |
| 20090187197 | Roeber et al. | Jul 2009 | A1 |
| 20090192530 | Adzich et al. | Jul 2009 | A1 |
| 20090204129 | Fronio | Aug 2009 | A1 |
| 20090216338 | Gingras et al. | Aug 2009 | A1 |
| 20090270999 | Brown | Oct 2009 | A1 |
| 20090281558 | Li et al. | Nov 2009 | A1 |
| 20090318752 | Evans et al. | Dec 2009 | A1 |
| 20100104608 | Abuzaina et al. | Apr 2010 | A1 |
| 20100130814 | Dubernard | May 2010 | A1 |
| 20100137679 | Lashinski et al. | Jun 2010 | A1 |
| 20100318108 | Datta | Dec 2010 | A1 |
| 20110015760 | Kullas | Jan 2011 | A1 |
| 20110054604 | Becker | Mar 2011 | A1 |
| 20110144667 | Horton et al. | Jun 2011 | A1 |
| 20110190795 | Hotter et al. | Aug 2011 | A1 |
| 20110238094 | Thomas et al. | Sep 2011 | A1 |
| 20110251699 | Ladet et al. | Oct 2011 | A1 |
| 20110257666 | Ladet et al. | Oct 2011 | A1 |
| 20110257761 | Mortarino | Oct 2011 | A1 |
| 20120004723 | Mortarino et al. | Jan 2012 | A1 |
| 20120016388 | Houard et al. | Jan 2012 | A1 |
| 20120029537 | Mortarino | Feb 2012 | A1 |
| 20120053690 | Frank | Mar 2012 | A1 |
| 20120065727 | Reneker et al. | Mar 2012 | A1 |
| 20120082712 | Stopek et al. | Apr 2012 | A1 |
| 20120116425 | Intoccia et al. | May 2012 | A1 |
| 20120150204 | Mortarino et al. | Jun 2012 | A1 |
| 20120165937 | Montanari et al. | Jun 2012 | A1 |
| 20120179175 | Hammell et al. | Jul 2012 | A1 |
| 20120179176 | Wilson et al. | Jul 2012 | A1 |
| 20120197415 | Montanari et al. | Aug 2012 | A1 |
| 20120226352 | Becker | Sep 2012 | A1 |
| 20120283826 | Moses et al. | Nov 2012 | A1 |
| 20130178875 | Horton et al. | Jul 2013 | A1 |
| 20130253645 | Kerr et al. | Sep 2013 | A1 |
| 20140044861 | Boey et al. | Feb 2014 | A1 |
| 20140100656 | Namnoum et al. | Apr 2014 | A1 |
| 20140276993 | Reilly et al. | Sep 2014 | A1 |
| 20140364684 | Lecuivre et al. | Dec 2014 | A1 |
| 20160051357 | Bailly | Feb 2016 | A1 |
| Number | Date | Country |
|---|---|---|
| 1317836 | May 1993 | CA |
| 201879864 | Jun 2011 | CN |
| 19544162 | Apr 1997 | DE |
| 19718903 | Dec 1997 | DE |
| 19751733 | Dec 1998 | DE |
| 19832634 | Jan 2000 | DE |
| 10019604 | Oct 2001 | DE |
| 10120942 | Oct 2001 | DE |
| 10043396 | Jun 2002 | DE |
| 0194192 | Sep 1986 | EP |
| 0248544 | Dec 1987 | EP |
| 0263360 | Apr 1988 | EP |
| 0276890 | Aug 1988 | EP |
| 0372969 | Jun 1990 | EP |
| 0531742 | Mar 1993 | EP |
| 0544485 | Jun 1993 | EP |
| 0552576 | Jul 1993 | EP |
| 0611561 | Aug 1994 | EP |
| 0614650 | Sep 1994 | EP |
| 0621014 | Oct 1994 | EP |
| 0625891 | Nov 1994 | EP |
| 0637452 | Feb 1995 | EP |
| 0664132 | Jul 1995 | EP |
| 0705878 | Apr 1996 | EP |
| 0719527 | Jul 1996 | EP |
| 0774240 | May 1997 | EP |
| 0797962 | Oct 1997 | EP |
| 0800791 | Oct 1997 | EP |
| 0827724 | Mar 1998 | EP |
| 0836838 | Apr 1998 | EP |
| 0847727 | Jun 1998 | EP |
| 0876808 | Nov 1998 | EP |
| 0895762 | Feb 1999 | EP |
| 0898944 | Mar 1999 | EP |
| 1017415 | Jul 2000 | EP |
| 1036545 | Sep 2000 | EP |
| 1052319 | Nov 2000 | EP |
| 1055757 | Nov 2000 | EP |
| 1090590 | Apr 2001 | EP |
| 1216717 | Jun 2002 | EP |
| 1216718 | Jun 2002 | EP |
| 0693523 | Nov 2002 | EP |
| 1273312 | Jan 2003 | EP |
| 1315468 | Jun 2003 | EP |
| 1382728 | Jan 2004 | EP |
| 1484070 | Dec 2004 | EP |
| 1561480 | Aug 2005 | EP |
| 1645232 | Apr 2006 | EP |
| 1674048 | Jun 2006 | EP |
| 1691606 | Aug 2006 | EP |
| 1782848 | May 2007 | EP |
| 2229918 | Sep 2010 | EP |
| 3000432 | Mar 2016 | EP |
| 2244853 | Apr 1975 | FR |
| 2257262 | Aug 1975 | FR |
| 2308349 | Nov 1976 | FR |
| 2453231 | Oct 1980 | FR |
| 2612392 | Sep 1988 | FR |
| 2682284 | Apr 1993 | FR |
| 2715309 | Jul 1995 | FR |
| 2715405 | Jul 1995 | FR |
| 2724563 | Mar 1996 | FR |
| 2730406 | Aug 1996 | FR |
| 2744906 | Aug 1997 | FR |
| 2766698 | Feb 1999 | FR |
| 2771622 | Jun 1999 | FR |
| 2773057 | Jul 1999 | FR |
| 2774277 | Aug 1999 | FR |
| 2779937 | Dec 1999 | FR |
| 2859624 | Dec 2005 | FR |
| 2876020 | Apr 2006 | FR |
| 2863277 | Jun 2006 | FR |
| 2884706 | Apr 2008 | FR |
| 2929834 | Oct 2009 | FR |
| 2953709 | Jun 2011 | FR |
| 1174814 | Dec 1969 | GB |
| 2051153 | Jan 1981 | GB |
| 2306110 | Apr 1997 | GB |
| H0332677 | Mar 1991 | JP |
| H05237128 | Sep 1993 | JP |
| H09137380 | May 1997 | JP |
| H11146888 | Jun 1999 | JP |
| 2008538300 | Oct 2008 | JP |
| 2011078767 | Apr 2011 | JP |
| 563828 | Sep 2011 | NZ |
| 8902445 | Mar 1989 | WO |
| 8908467 | Sep 1989 | WO |
| 9012551 | Nov 1990 | WO |
| 9206639 | Apr 1992 | WO |
| 9220349 | Nov 1992 | WO |
| 9310731 | Jun 1993 | WO |
| 9311805 | Jun 1993 | WO |
| 9318174 | Sep 1993 | WO |
| 9417747 | Aug 1994 | WO |
| 9507666 | Mar 1995 | WO |
| 9518638 | Jul 1995 | WO |
| 9532687 | Dec 1995 | WO |
| 9603091 | Feb 1996 | WO |
| 9608277 | Mar 1996 | WO |
| 9609795 | Apr 1996 | WO |
| 9614805 | May 1996 | WO |
| 9641588 | Dec 1996 | WO |
| 9735533 | Oct 1997 | WO |
| 9835632 | Aug 1998 | WO |
| 9849967 | Nov 1998 | WO |
| 9905990 | Feb 1999 | WO |
| 9906079 | Feb 1999 | WO |
| 9906080 | Feb 1999 | WO |
| 9951163 | Oct 1999 | WO |
| 0016821 | Mar 2000 | WO |
| 0067663 | Nov 2000 | WO |
| 0115625 | Mar 2001 | WO |
| 0180773 | Nov 2001 | WO |
| 0181667 | Nov 2001 | WO |
| 0207648 | Jan 2002 | WO |
| 0217853 | Mar 2002 | WO |
| 02078568 | Oct 2002 | WO |
| 03002168 | Jan 2003 | WO |
| 2004004600 | Jan 2004 | WO |
| 2004071349 | Aug 2004 | WO |
| 2004078120 | Sep 2004 | WO |
| 2004096098 | Nov 2004 | WO |
| 2004103212 | Dec 2004 | WO |
| 2005011280 | Feb 2005 | WO |
| 2005013863 | Feb 2005 | WO |
| 2005018698 | Mar 2005 | WO |
| 2005048708 | Jun 2005 | WO |
| 2005105172 | Nov 2005 | WO |
| 2006018552 | Feb 2006 | WO |
| 2006023414 | Mar 2006 | WO |
| 2007004214 | Jan 2007 | WO |
| 2008066883 | Jun 2008 | WO |
| 2009039373 | Mar 2009 | WO |
| 2009071998 | Jun 2009 | WO |
| 2009031035 | Jan 2010 | WO |
| 2010043978 | Apr 2010 | WO |
| 2007048099 | Sep 2010 | WO |
| 2011007062 | Jan 2011 | WO |
| 2011026987 | Mar 2011 | WO |
| 2011038740 | Apr 2011 | WO |
| 2014041577 | Mar 2014 | WO |
| Entry |
|---|
| Communication pursuant to Article 94(3) EPC issued in European Application No. 17305489.1 dated Feb. 19, 2021, 6 pages. |
| Chinese Office Action issued in Chinese Application No. 201810386483.1 dated Apr. 2, 2021 with English Translation. |
| Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
| Blondin, C. et al. “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
| Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
| Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
| Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
| Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506. |
| Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25. |
| Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany. |
| European Search Report for EP 15305634.6 dated Nov. 2, 2015 (3 pages). |
| European Search Report for EP17305489.1 dated Oct. 25, 2017 (3 pages). |
| Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, 7 pp. 189-201, 52(2),published online Nov. 2009. |
| Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
| Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
| Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
| Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26. |
| Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
| Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
| Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
| Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7). |
| Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. IL Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
| Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
| Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
| O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
| Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
| Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
| Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
| Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004,pp. 211-220,18(2). |
| Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
| Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
| Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
| Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3). |
| Number | Date | Country | |
|---|---|---|---|
| 20200297472 A1 | Sep 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15965826 | Apr 2018 | US |
| Child | 16895888 | US |
